Transient versus Persistent Donor Specific Antibodies and Outcomes After Lung Transplantation

Purpose: De novo donor-specific antibodies (dnDSAs) and antibody-mediated rejection (AMR) have gained significant interest over the last years. However, little is known about the clinical significance of transient versus persistent dnDSAs and their impact on patient outcomes and graft survival.

Source: The Journal of Heart and Lung Transplantation - April 1, 2024 Category: Transplant Surgery Authors: , C. Hillebrand, P.M. Boehm, J. Boecker, D. Koren, S. Schwarz, Z. Kovacs, G. Murakoezy, E. Hielle-Wittmann, G. Fischer, C. Aigner, K. Hoetzenecker, P. Jaksch, A. Benazzo Source Type: research